119 related articles for article (PubMed ID: 36216101)
1. A decennary update on diverse heterocycles and their intermediates as privileged scaffolds for cathepsin B inhibition.
Saroha B; Kumar G; Kumari M; Kaur R; Raghav N; Sharma PK; Kumar N; Kumar S
Int J Biol Macromol; 2022 Dec; 222(Pt B):2270-2308. PubMed ID: 36216101
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of a Humanized Antibody Inhibitor of Cathepsin B.
Dai Z; Cheng Q; Zhang Y
Biochemistry; 2020 Apr; 59(14):1420-1427. PubMed ID: 32212642
[TBL] [Abstract][Full Text] [Related]
3. BODIPY-Caged Photoactivated Inhibitors of Cathepsin B Flip the Light Switch on Cancer Cell Apoptosis.
Toupin NP; Arora K; Shrestha P; Peterson JA; Fischer LJ; Rajagurubandara E; Podgorski I; Winter AH; Kodanko JJ
ACS Chem Biol; 2019 Dec; 14(12):2833-2840. PubMed ID: 31750642
[TBL] [Abstract][Full Text] [Related]
4. Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
Cermak S; Kosicek M; Mladenovic-Djordjevic A; Smiljanic K; Kanazir S; Hecimovic S
PLoS One; 2016; 11(11):e0167428. PubMed ID: 27902765
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Medicinally Privileged Heterocycles through Dielectric Heating.
Bandyopadhyay D; Banik BK
Curr Med Chem; 2017; 24(41):4596-4626. PubMed ID: 28240166
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
7. IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation.
Lei T; Ling X
World J Gastroenterol; 2015 Sep; 21(35):10137-49. PubMed ID: 26401078
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.
Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T
Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449
[TBL] [Abstract][Full Text] [Related]
9. The effect of 3-bromopyruvate on the properties of cathepsin B in the aspect of metastatic potential of colon cancer cells.
Szczuka I; Wiśniewski J; Kustrzeba-Wójcicka I; Terlecki G
Adv Clin Exp Med; 2020 Aug; 29(8):949-957. PubMed ID: 32820873
[TBL] [Abstract][Full Text] [Related]
10. Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B-mediated degradation of BRCA1.
Wang Y; Niu H; Hu Z; Zhu M; Wang L; Han L; Qian L; Tian K; Yuan H; Lou H
J Cell Mol Med; 2019 Mar; 23(3):1798-1812. PubMed ID: 30565390
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B Activity Initiates Apoptosis via Digestive Protease Activation in Pancreatic Acinar Cells and Experimental Pancreatitis.
Sendler M; Maertin S; John D; Persike M; Weiss FU; Krüger B; Wartmann T; Wagh P; Halangk W; Schaschke N; Mayerle J; Lerch MM
J Biol Chem; 2016 Jul; 291(28):14717-31. PubMed ID: 27226576
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice.
Gonzalez EA; Martins GR; Tavares AMV; Viegas M; Poletto E; Giugliani R; Matte U; Baldo G
Life Sci; 2018 Mar; 196():102-109. PubMed ID: 29366749
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome.
Bai H; Yang B; Yu W; Xiao Y; Yu D; Zhang Q
Exp Cell Res; 2018 Jan; 362(1):180-187. PubMed ID: 29196167
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma.
Tan G; Liu Q; Tang X; Kang T; Li Y; Lu J; Zhao X; Tang F
BMC Cancer; 2016 Mar; 16():241. PubMed ID: 26995190
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.
Sevenich L; Schurigt U; Sachse K; Gajda M; Werner F; Müller S; Vasiljeva O; Schwinde A; Klemm N; Deussing J; Peters C; Reinheckel T
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2497-502. PubMed ID: 20133781
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin proteases promote angiogenic sprouting and laser-induced choroidal neovascularisation in mice.
Bühler A; Berger S; Bengsch F; Martin G; Han H; Vierkotten S; Pielen A; Boehringer D; Schlunck G; Fauser S; Agostini HT; Reinheckel T; Stahl A
Exp Eye Res; 2013 Oct; 115():73-8. PubMed ID: 23800510
[TBL] [Abstract][Full Text] [Related]
17. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B is not the processing enzyme for mouse prorenin.
Mercure C; Lacombe MJ; Khazaie K; Reudelhuber TL
Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1212-6. PubMed ID: 20164204
[TBL] [Abstract][Full Text] [Related]
19. Structurally diversified heterocycles and related privileged scaffolds as potential urease inhibitors: a brief overview.
Ibrar A; Khan I; Abbas N
Arch Pharm (Weinheim); 2013 Jun; 346(6):423-46. PubMed ID: 23712847
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
